425 related articles for article (PubMed ID: 22467778)
21. A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial data.
Xenakis JG; Kinter ET; Ishak KJ; Ward AJ; Marton JP; Willke RJ; Davies S; Caro JJ
Pharmacoeconomics; 2011 Jun; 29(6):497-510. PubMed ID: 21452908
[TBL] [Abstract][Full Text] [Related]
22. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of the nicotine vaccine 3'-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation: a randomized placebo-controlled trial.
Hoogsteder PH; Kotz D; van Spiegel PI; Viechtbauer W; van Schayck OC
Addiction; 2014 Aug; 109(8):1252-9. PubMed ID: 24894625
[TBL] [Abstract][Full Text] [Related]
24. Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.
Hajek P; McRobbie HJ; Myers KE; Stapleton J; Dhanji AR
Arch Intern Med; 2011 Apr; 171(8):770-7. PubMed ID: 21518946
[TBL] [Abstract][Full Text] [Related]
25. Characteristics and abstinence outcomes among tobacco quitline enrollees using varenicline or nicotine replacement therapy.
Biazzo LL; Froshaug DB; Harwell TS; Beck HN; Haugland C; Campbell SL; Helgerson SD
Nicotine Tob Res; 2010 Jun; 12(6):567-73. PubMed ID: 20378640
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR
Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342
[TBL] [Abstract][Full Text] [Related]
27. A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers.
Tsai ST; Cho HJ; Cheng HS; Kim CH; Hsueh KC; Billing CB; Williams KE
Clin Ther; 2007 Jun; 29(6):1027-39. PubMed ID: 17692719
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of a flexible quit date versus an a priori quit date approach to smoking cessation: a cross-study analysis.
Hughes JR; Russ CI; Arteaga CE; Rennard SI
Addict Behav; 2011 Dec; 36(12):1288-91. PubMed ID: 21872998
[TBL] [Abstract][Full Text] [Related]
29. Varenicline to stop long-term nicotine replacement use: a double-blind, randomized, placebo-controlled trial.
Tønnesen P; Mikkelsen K
Nicotine Tob Res; 2013 Feb; 15(2):419-27. PubMed ID: 23024246
[TBL] [Abstract][Full Text] [Related]
30. The efficacy and safety of a nicotine conjugate vaccine (NicVAX®) or placebo co-administered with varenicline (Champix®) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trial.
Hoogsteder PH; Kotz D; van Spiegel PI; Viechtbauer W; Brauer R; Kessler PD; Kalnik MW; Fahim RE; van Schayck OC
BMC Public Health; 2012 Dec; 12():1052. PubMed ID: 23216646
[TBL] [Abstract][Full Text] [Related]
31. A comparison of the content-, construct- and predictive validity of the cigarette dependence scale and the Fagerström test for nicotine dependence.
Etter JF
Drug Alcohol Depend; 2005 Mar; 77(3):259-68. PubMed ID: 15734226
[TBL] [Abstract][Full Text] [Related]
32. Changes in health-related quality of life with smoking cessation treatment.
Hays JT; Croghan IT; Baker CL; Cappelleri JC; Bushmakin AG
Eur J Public Health; 2012 Apr; 22(2):224-9. PubMed ID: 20884658
[TBL] [Abstract][Full Text] [Related]
33. Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study.
Chengappa KN; Perkins KA; Brar JS; Schlicht PJ; Turkin SR; Hetrick ML; Levine MD; George TP
J Clin Psychiatry; 2014 Jul; 75(7):765-72. PubMed ID: 25006684
[TBL] [Abstract][Full Text] [Related]
34. Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial.
Ebbert JO; Hughes JR; West RJ; Rennard SI; Russ C; McRae TD; Treadow J; Yu CR; Dutro MP; Park PW
JAMA; 2015 Feb; 313(7):687-94. PubMed ID: 25688780
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of varenicline for smoking cessation.
Hays JT; Ebbert JO; Sood A
Am J Med; 2008 Apr; 121(4 Suppl 1):S32-42. PubMed ID: 18342165
[TBL] [Abstract][Full Text] [Related]
36. Adherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherence.
Hays JT; Leischow SJ; Lawrence D; Lee TC
Nicotine Tob Res; 2010 Jun; 12(6):574-81. PubMed ID: 20457644
[TBL] [Abstract][Full Text] [Related]
37. Treatment of nicotine dependence with Chantix (varenicline).
Rankin KV; Jones DL
Tex Dent J; 2011 May; 128(5):457-61. PubMed ID: 21834368
[TBL] [Abstract][Full Text] [Related]
38. The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline.
Foulds J
Int J Clin Pract; 2006 May; 60(5):571-6. PubMed ID: 16700857
[TBL] [Abstract][Full Text] [Related]
39. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
Stapleton JA; Watson L; Spirling LI; Smith R; Milbrandt A; Ratcliffe M; Sutherland G
Addiction; 2008 Jan; 103(1):146-54. PubMed ID: 18028247
[TBL] [Abstract][Full Text] [Related]
40. Varenicline does not increase serum BDNF levels in patients with nicotine dependence.
Umene-Nakano W; Yoshimura R; Yoshii C; Hoshuyama T; Hayashi K; Hori H; Katsuki A; Ikenouchi-Sugita A; Nakamura J
Hum Psychopharmacol; 2010 Apr; 25(3):276-9. PubMed ID: 20373480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
